Jeroen is the Co-Founder and CEO of Semarion, an advanced materials company spun out from the Cavendish Laboratory in Cambridge. Their mission is to accelerate in vitro drug discovery by tackling adherent cell assays, a fundamental bottleneck for rapid data generation. The proprietary SemaCyte platform leverages novel materials physics to shift the paradigm of how cell models are handled, stored, and assayed. By barcoding and mobilising adherent cells, they uniquely supercharge existing biopharma workflows to deliver 10x throughput gains and 6x cost reductions, ushering in the next generation of cell biology automation.
Disclosure information not submitted.
Semarion - Shifting the Adherent Cell Assay Paradigm for 10x Gains in Data Generation
Tuesday, May 28, 2024
13:30 – 13:40 CEST